CMPC subsidiary Softys Brazil completes acquisition of Carta Fabril, according to previously announced terms and conditions; Carta Fabril produces tissue paper products, personal-care items such as baby diapers, adult diapers, feminine care and wet wipes

Sample article from our Tissue & Hygiene

SANTIAGO , May 31, 2022 (press release) –

Dear Financial Market Commission: Pursuant to Articles 9 and 10 third subparagraph in Law 18.045 of the Securities Market Law and to General Rule 30 of the Financial Market Commission, please be advised that under due authority, I hereby notify you that today, the subsidiary Softys Brazil signed the “Termo de Fechamento”, through which it took control of Carta Fabril, as previously informed to the market by material disclosed dated October 29, 2021.The takeover took place according to terms and conditions set forth in the above material disclosure priorly mentioned.

Sincerely yours,

Francisco Ruiz-Tagle Edwards

Chief Executive Officer


* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order tissue & hygiene coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.